The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [1] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Doh, Fa Mee
    Chang, Tae-Ik
    Koo, Hyang Mo
    Lee, Mi Jung
    Shin, Dong Ho
    Kim, Chan Ho
    Ko, Kwang Il
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Dae-Suk
    Han, Seung Hyeok
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (06) : 501 - 509
  • [2] THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESISTANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Chang, Tae Ik
    Shin, Dong Ho
    Oh, Hyung Jung
    Kang, Shin-Wook
    Han, Dae-Suk
    Yoo, Tae-Hyun
    Han, Seung Hyeok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 471 - 472
  • [3] Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients
    James B. Wetmore
    Jonathan D. Mahnken
    Purna Mukhopadhyay
    Qingjiang Hou
    Edward F. Ellerbeck
    Sally K. Rigler
    John A. Spertus
    Theresa I. Shireman
    Journal of General Internal Medicine, 2012, 27 : 1475 - 1483
  • [4] EFFECTS OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) IN HYPERCHOLESTEROLEMIC PATIENTS ON DIALYSIS
    VILLORIA, JG
    MOLINA, HD
    LOPEZ, AG
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1453 - 1454
  • [5] Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients
    Wetmore, James B.
    Mahnken, Jonathan D.
    Mukhopadhyay, Purna
    Hou, Qingjiang
    Ellerbeck, Edward F.
    Rigler, Sally K.
    Spertus, John A.
    Shireman, Theresa I.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (11) : 1475 - 1483
  • [6] Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
    Han, Seung Hyeok
    Kang, Ea Wha
    Yoon, Se-Jung
    Yoon, Hyang Sook
    Lee, Hyun Chul
    Yoo, Tae Hyun
    Choi, Kyu Hun
    Han, Dae-Suk
    Kang, Shin-Wook
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) : 3722 - 3728
  • [7] Are HMG-CoA reductase inhibitors underutilized in dialysis patients?
    Seliger, SL
    Stehman-Breen, CO
    SEMINARS IN DIALYSIS, 2003, 16 (03) : 179 - 185
  • [8] Insulin Resistance in Patients Undergoing Peritoneal Dialysis: Can We Improve It?Editorial to: “The Effect of HM-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis” by Fa Mee Doh et al.
    Kelli King-Morris
    T. Alp Ikizler
    Cardiovascular Drugs and Therapy, 2012, 26 (6) : 441 - 443
  • [9] EFFECT OF FOOD ON THE BIOAVAILABILITY OF ATORVASTATIN, AN HMG-COA REDUCTASE INHIBITOR
    RADULOVIC, LL
    CILLA, DD
    POSVAR, EL
    SEDMAN, AJ
    WHITFIELD, LR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (10): : 990 - 994
  • [10] The effect of the HMG-CoA reductase inhibitor, simvastatin, on the renal microcirculation
    Inman, SR
    Caprio, TW
    Drummond, EE
    Mueller, ME
    FASEB JOURNAL, 2005, 19 (05): : A1145 - A1146
12345